FAM53A is a protein implicated in multiple disease contexts through gene expression regulation. While UniProt annotations suggest a potential role in neural development and protein nuclear import, the primary evidence supporting FAM53A's biological significance comes from disease association studies. In cancer biology, FAM53A expression associates with bladder cancer risk, with higher expression levels correlating with increased disease susceptibility 1. Additionally, FAM53A was identified as a regulatory target gene that modulates doxorubicin sensitivity in breast cancer cells, indicating a potential role in chemotherapeutic response 2. Genetic studies reveal FAM53A localization within critical genomic regions. It maps to chromosome 4.3, a region containing genes associated with Wolf-Hirschhorn syndrome-related fetal growth retardation, though TACC3 and SLBP are the primary candidate genes in this interval 3. FAM53A also shows colocalization with multiple osteoarthritis GWAS signals in osteoclast eQTL analyses, suggesting regulatory roles in bone disease pathogenesis 4. These findings indicate FAM53A functions as a genetically-regulated modulator affecting cancer susceptibility and potentially bone disease progression, though mechanistic details remain incompletely characterized.